Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H12N2O |
Molecular Weight | 236.2686 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
InChI
InChIKey=FFGPTBGBLSHEPO-UHFFFAOYSA-N
InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)
Molecular Formula | C15H12N2O |
Molecular Weight | 236.2686 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:38:29 UTC 2023
by
admin
on
Sat Dec 16 17:38:29 UTC 2023
|
Record UNII |
33CM23913M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
||
|
NDF-RT |
N0000008486
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
||
|
NDF-RT |
N0000175753
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
24.2.2
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
||
|
NDF-RT |
N0000175751
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
43590
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
||
|
FDA ORPHAN DRUG |
265508
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
||
|
WHO-ATC |
N03AF01
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
||
|
LIVERTOX |
NBK548097
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
||
|
WHO-VATC |
QN03AF01
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/16/1746
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
05
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB06113MIG
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
Carbamazepine
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
169864
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
DTXSID4022731
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
298-46-4
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
3019
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
206-062-7
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
33CM23913M
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
CARBAMAZEPINE
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
CHEMBL108
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
33CM23913M
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
N0000191266
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | Cytochrome P450 1A2 Inducers [MoA] | ||
|
100000092127
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
2554
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
m3053
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | Merck Index | ||
|
2002
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | RxNorm | ||
|
489
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
DB00564
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
1836
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
C341
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
N0000185607
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | Cytochrome P450 2C19 Inducers [MoA] | ||
|
D002220
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
CARBAMAZEPINE
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | Description: A white to yellowish white, crystalline powder; odourless or almost odourless. Solubility: Practically insoluble in water and ether R; soluble in ethanol (~750 g/l) TS. Category: Antiepileptic drug. Storage: Carbamazepine should be kept in a tightly closed container. Definition: Carbamazepine contains not less than 98.0% and not more than 102.0% of C15H12N2O, calculated with reference to the dried substance. | ||
|
N0000187064
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | Cytochrome P450 2B6 Inducers [MoA] | ||
|
3387
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
N0000185507
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | Cytochrome P450 2C9 Inducers [MoA] | ||
|
1093001
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
5339
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | |||
|
N0000185506
Created by
admin on Sat Dec 16 17:38:34 UTC 2023 , Edited by admin on Sat Dec 16 17:38:34 UTC 2023
|
PRIMARY | Cytochrome P450 3A4 Inducers [MoA] |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS | |||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
TRANSPORTER -> INDUCER | |||
|
METABOLIC ENZYME -> INDUCER | |||
|
TARGET -> INHIBITOR |
|
||
|
BINDER->LIGAND |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> INDUCER | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
|
||
|
METABOLIC ENZYME -> INDUCER |
POTENT
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
MAJOR
URINE
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
PARENT -> IMPURITY |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
MINOR
URINE
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||